Philadelphia University + Thomas Jefferson University

Publications

Highlighted Publications

Fu X, Wan S, Hann HW, Myers RE, Hann RS, Au J, Chen B, Xing J, Yang H. Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection. Eur J Cancer, 2012, 48 (7): 1014-22.


Li L, Hann HW, Wan S, Hann RS, Wang C, Lai Y, Ye X, Evans A, Myers RE, Ye Z, Li B, Xing J, Yang H. Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection. Sci Rep, 2016.


Wang C, Hann HW, Ye Z, Hann RS, Wan S, Ye X, Block PD, Li B, Myers RE, Wang X, Juon HS, Civan J, Chang M, Bae HS, Xing J, Yang H. Prospective evidence of a circulating microRNA signature as a non-invasive marker of hepatocellular carcinoma in HBV patients. Oncotarget, 2016.


Mu Z, Wang C, Ye Z, Austin L, Civan J, Hyslop T, Palazzo JP, Jaslow R, Li B, Myers RE, Jiang J, Xing J, Yang H, Cristofanilli M. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer. Breast Cancer Res Treat, 2015, 154 (3): 563-71.


Lai Y, Wang C, Civan JM, Palazzo JP, Ye Z, Hyslop T, Lin J, Myers RE, Li B, Jiang B, Sama A, Xing J, Yang H. Effects of cancer stage and treatment differences on racial disparities in survival from colon cancer: a United States population-based study. Gastroenterology, 2016, 150 (5): 1135-46.


Recent Publications

Polymorphisms in genes related to epithelial-mesenchymal transition and risk of non-small cell lung cancer

Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancer

Genetic variations of mitochondrial genome modify risk and prognosis of hepatocellular carcinoma patients

Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework

Prospective and longitudinal evaluations of telomere length of circulating DNA as a risk predictor of hepatocellular carcinoma in HBV patients

Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer

Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis

Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization

Detection and characterization of circulating tumor associated cells in metastatic breast cancer

Prospective changes in global DNA methylation and cancer incidence and mortality

Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival from Colon Cancer: A United States Population-Based Study

Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection

Intraoperative ultrasonography for the identification of thoracic recurrent laryngeal nerve lymph nodes in patients with esophageal cancer

The doylestown algorithm: A test to improve the performance of afp in the detection of hepatocellular carcinoma

Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer

The effects of erythropoiesis-stimulating agents on the short-term and long-term survivals in metastatic breast cancer patients receiving chemotherapy: a SEER population-based study

Network-based stratification analysis of 13 major cancer types using mutations in panels of cancer genes

Circulating Mitochondrial DNA Content Associated with the Risk of Liver Cirrhosis: A Nested Case–Control Study

Polymorphisms in genes of tricarboxylic acid cycle key enzymes are associated with early recurrence of hepatocellular carcinoma

Racial disparity in breast cancer survival: the impact of pre-treatment hematologic variables